The upside comes from turning a regulatory lead into one
bankable U.S. program plus follow-on services, not from assuming a broad fleet is already operating by 2031. A
premium multiple is justified if NuScale proves its approval moat can reliably pull financing, siting and supply partners into repeatable projects, but I stop short of a moonshot because partner dependence and
dilution can still absorb much of the value.